The B-cell epitope of the monoclonal anti-factor VIII antibody ESH8 characterized by peptide array analysis

Thrombosis and Haemostasis

Volumn 99, Issue 3, 2008, Pages 634-637

  Albert, Thilo ^a   Egler, Christian ^b   Jakuschev, Stanislav ^c   Schuldenzucker, Ulrike ^b   Schmitt, Alexandra ^a   Brokemper, Oliver ^b   Zabe Kühn, Martin ^b,d   Hoffmann, Daniel ^b,c   Oldenburg, Johannes ^a   Schwaab, Rainer ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b CENTER OF ADVANCED EUROPEAN STUDIES AND RESEARCH CAESAR   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

^d GERMAN AEROSPACE CENTER DLR   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; BLOOD CLOTTING FACTOR 8; CYSTEINE; EPITOPE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY ESH8; PEPTIDE LIBRARY; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIGEN BINDING; B LYMPHOCYTE; BAY REGION BINDING SITE; EPITOPE MAPPING; HUMAN; LETTER; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN MICROARRAY; PROTEIN MOTIF; PROTEOMICS;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; EPITOPE MAPPING; EPITOPES, B-LYMPHOCYTE; FACTOR VIII; HUMANS; MALE; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; PROTEIN ARRAY ANALYSIS; PROTEIN CONFORMATION;

EID: 42249088890     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-06-0400     Document Type: Letter

References (12)

1. Griffin BD, Micklem LR, McCann MC, et al. The production and characterisation of a panel of ten murine monoclonal antibodies to human procoagulant factor VIII. Thromb Haemost 1986; 55: 40-46.
2. Scandella D, Gilbert GE, Shima M, et al. Some factor VIII inhibitor antibodies recognize a common epitope corresponding to C2 domain amino acids 2248 through 2312, which overlap a phospholipid-binding site. Blood 1995; 86: 1811-1819.
3. Peerlinck K, Jacquemin MG, Arnout J, et al. Antifactor VIII antibody inhibiting allogeneic but not autologous factor VIII in patients with mild hemophilia A. Blood 1999; 93: 2267-2273.
4. Saenko EL, Shima M, Gilbert GE, et al. Slowed release of thrombin-cleaved factor VIII from von Willebrand factor by a monoclonal and a human antibody is a novel mechanism for factor VIII inhibition. J Biol Chem 1996; 271: 27424-27431.
5. Nogami K, Shima M, Hosokawa K, et al. Role of factor VIII C2 domain in factor VIII binding to factor Xa. J Biol Chem 1999; 274: 31000-31007.
6. Ahmad SS, Walsh PN. Role of the C2 domain of factor VIIIa in the assembly of factor-X activating complex on the platelet membrane. Biochemistry 2005; 44: 13858-13865.
7. Saenko EL, Scandella D, Yakhyaev AV, et al. Activation of factor VIII by thrombin increases its affinity for binding to synthetic phospholipid membranes and activated platelets. J Biol Chem 1998; 273: 27918-27926.
8. Villard S, Piquer D, Raut S, et al. Low molecular weight peptides restore the procoagulant activity of factor VIII in the presence of the potent inhibitor antibody ESH8. J Biol Chem 2002; 277: 27232-27239.
9. Pratt KP, Shen BW, Takeshima K, et al. Structure of the C2 domain of human factor VIII at 1.5 A resolution. Nature 1999; 402: 439-442.
10. Spiegel PC Jr, Jacquemin M, Saint-Remy JM, et al. Structure of a factor VIII C2 domain-immunoglobulin G4kappa Fab complex: identification of an inhibitory antibody epitope on the surface of factor VIII. Blood 2001; 98: 13-19.
11. Myszka DG. Improving biosensor analysis. J Mol Recogn 1999; 12: 279-284.
12. Kopecky E-M, Greinstetter S, Pabinger I, Buchacher A, Römisch J, Jungbauer A. Mapping of FVIII inhibitor epitopes using cellulose-bound synthetic peptide arrays. J Immunol Methods 2006; 308: 90-100.